Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Sahoko NinomiyaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Yukari IshiguroDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Hisashi HasumiDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.ORCID 0000-0001-8211-8835
Ryosuke JikuyaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Akihito HashizumeDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.ORCID 0009-0008-1054-0779
Masanobu YamazakiDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Jun-Ichi TeranishiDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Kazuhide MakiyamaDepartment of Urology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.ORCID 0000-0002-7449-2015
Hiroji UemuraDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Hiroshi MiyamotoDepartments of Pathology & Laboratory Medicine and Urology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-7610-7769
Takashi KawaharaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Role of FGFR3 in the Progression of Bladder Cancer. · full record | OpenQuestion